Cholelithiasis

Council on Scientific Affairs. Pharmaceutical dissolution of gallstones. JAMA 1983; 250: 2373–4.

Ranofsky AL . Surgical operations in short-stay hospitals: United States 1975. Hyattsville, MD: National Center for Health Statistics: 1978 DHEW publication no. (PHS) 78-1785 (Vital and Health Statistics: Series 13: No. 34).

Friedman GD Kannel WB Dawber TR . The epidemiology of gallbladder disease: Observations in the Framingham study. J Chronic Dis 1966; 19: 273–92.

Heiss FW Ross RL Scholz FJ . Common bile duct calculi. Parts 1 and 2. Postgrad Med 1984; 75: 88–104, 109–18.

Schoenfield LJ Lachin JM Baum RA . Chenodiol (chenodeoxycholic acid) for dissolution of gallstones: The National Cooperative Gallstone Study. Ann Intern Med 1981; 95: 257–82.

Carey WD Tangedahl TN . Medical therapy for gallstones. Postgrad Med 1982; 71: 163–72.

Klassen CD Watkins JB . Mechanisms of bile formation, hepatic uptake and biliary excretion. Pharmacol Rev 1984; 36: 1–67.

Jones RS Meyers WC . Regulation of hepatic biliary secretion. Ann Rev Physiol 1979; 41: 67–82.

Salen G Shefer S . Bile acid synthesis. Ann Rev Physiol 1983; 45: 679–85.

Pearlman BJ . Gallstones: The present and future of medical dissolution. Med Clin North Am 1976; 62: 87–105.

Gregory PB . Gallstones and biliary tract disease. Sci Am 1986; 9 (12) 1–9.

Hofmann AF . The enterohepatic circulation of bile acids in man. Clin Gastroenterol 1977; 6: 3–23.

Bolt RJ . Pathophysiology of gallbladder disease. In: Sodeman WA Sodeman TA , eds. Pathologic physiology. 5th ed. Philadelphia: WB Saunders, 1974: 818–26.

Berne RM Levy MN , eds. Physiology. St. Louis: CV Mosby, 1983: 786–94.

Smith BF LaMont TJ . The pathogenesis of gallstones. Hosp Pract 1984; 12: 93–104.

Admirand WH Small DM . The physico-chemical basis of cholesterol gallstone formation. J Clin Invest 1968; 47: 1043–52.

Holzbach RT Kibe A Thiel E . Biliary proteins: Unique inhibitors of cholesterol crystal nucleation in human gallbladder bile. J Clin Invest 1984; 73: 35–45.

Maki T . Pathogenesis of calcium bilirubinate stones: Role of E. coli, beta-glucuronidase and coagulation by inorganic ions, polyelectrolytes and agitation. Ann Surg 1966; 164: 90–100.

Boonyapisit ST Trotman BW Ostrow JD . Unconjugated bilirubin and the hydrolysis of conjugated bilirubin in gallbladder bile of patients with cholelithiasis. Gastroenterology 1978; 74: 70–4.

Wheeler M Hills LL Laby B . Cholelithiasis: A clinical and dietary survey. Gut 1970; 11: 430–7.

Jaffe RH . Cholelithiasis: Statistical study with special reference to its frequency in colored race. J Lab Clin Med 1933; 18: 1220–7.

Ludlow AI . Autopsy incidence cholelithiasis. Am J Med Sci 1937; 193: 481.

Maki T . Cholelithiasis in the Japanese. Arch Surg 1961; 82: 599–611.

Sturdevant RAL Pearce ML Dayton S . Increased prevalence of cholelithiasis in men ingesting a serum-cholesterol lowering diet. N Engl J Med 1973; 288: 24–7.

Einarsson K Nilsell K Barbro L . Influence of age on secretion of cholesterol and synthesis of bile acids by the liver. N Engl J Med 1985; 313: 277–82.

Pitt H King W Mann L . Increased risk of cholelithiasis with prolonged total parenteral nutrition. Am J Surg 1983; 145: 106–11.

USPDI drug information for the health care provider. 6th ed. Rockville, MD: United States Pharmacopeial Convention, 1985: 519, 540, 555, 661, 777, 809.

Bateson M Maclean D Ross P Bouchier I . Clofibrate therapy and gallstone induction. Dig Dis Sci 1978: 23: 623–8.

Committee of Principal Investigators. A cooperative trial in the primary prevention of ischemic heart disease using clofibrate. Br Heart J 1978; 40: 1069–118.

Boston Collaborative Drug Surveillance Program. Oral contraceptive and venous thromboembolic disease, surgically confirmed gallbladder disease and breast tumors. Lancet 1973; 1: 1399–404.

Benion LJ Grun LJ Grundy SM . Risk factors for the development of cholelithiasis. N Engl J Med 1978; 299: 1161–7, 1221–7.